Answers are grounded in this paper and cite their sources.
Background: Human Cytomegalovirus (HCMV) is a widespread herpesvirus that remains latent in the body of healthy individuals and reactivates during the weakness of the immune system.This virus has been implicated in many malignancies and has been found to cause graft rejections and several other complications.This study aimed to determine the prevalence of HCMV-DNA viremia among breast cancer, and associate it the type and grade of the cancer.Methods: 88-female patients with confirmed breast cancer have been included in the study.Blood samples (5 ml) were collected from patients at armed forces hospitals from January 2023 to March 2024.Detection of CMV-DNA is achieved through molecular methods, specifically using quantitative PCR (qPCR) with the COBAS 5800 system.Statistical analysis was performed by Chi-square test of independence with P value significant < 0.05.Results: HCMV-DNA detected in 11.3% (10:88) of the cases.Among these, 9 cases were ductal carcinoma, and single was medullary carcinoma.HCMV prevalence was highest in grade I tumour (6 cases), then by grade II (2 cases), and grade III (2 cases).Most cases exhibited low viral load (8:10), while only two cases has medium viral load.Conclusion: Our Results suggests a low prevalence of HCMV-DNA viremia among our study participants, most cases detected in ductal carcinoma, and early-stage tumour.Further research is essential and required to classify HCMV role in breast cancer progression and prognosis.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: